Alix Collard

551 total citations
15 papers, 369 citations indexed

About

Alix Collard is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Alix Collard has authored 15 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Microbiology. Recurrent topics in Alix Collard's work include Bacterial Infections and Vaccines (6 papers), Pneumonia and Respiratory Infections (5 papers) and HIV Research and Treatment (4 papers). Alix Collard is often cited by papers focused on Bacterial Infections and Vaccines (6 papers), Pneumonia and Respiratory Infections (5 papers) and HIV Research and Treatment (4 papers). Alix Collard collaborates with scholars based in Belgium, United Kingdom and United States. Alix Collard's co-authors include Jeanne‐Marie Jacquet, Fred Zepp, Markus Knuf, Lode Schuerman, Marguerite Koutsoukos, Patricia Bourguignon, Michel Janssens, Gérald Voss, Christine Farvacques and Frédéric Clément and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and The Journal of Pediatrics.

In The Last Decade

Alix Collard

14 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alix Collard Belgium 12 180 140 115 68 58 15 369
Miroslav Špliňo Czechia 9 256 1.4× 54 0.4× 66 0.6× 27 0.4× 34 0.6× 30 365
James Matthias United States 12 146 0.8× 176 1.3× 134 1.2× 118 1.7× 19 0.3× 34 450
Alemnew F. Dagnew United States 12 248 1.4× 51 0.4× 93 0.8× 87 1.3× 41 0.7× 20 336
Amalia Magaret United States 11 221 1.2× 86 0.6× 117 1.0× 40 0.6× 43 0.7× 22 367
Jason Martin United States 11 178 1.0× 34 0.2× 217 1.9× 89 1.3× 18 0.3× 20 348
Sarah Gwyn United States 12 184 1.0× 224 1.6× 63 0.5× 55 0.8× 51 0.9× 35 375
Richard Garceau Canada 12 127 0.7× 217 1.6× 76 0.7× 42 0.6× 21 0.4× 26 397
Wen‐Chun Liu Taiwan 11 139 0.8× 51 0.4× 193 1.7× 27 0.4× 20 0.3× 20 376
I Vodopija Croatia 10 172 1.0× 62 0.4× 101 0.9× 48 0.7× 15 0.3× 31 293
V. Bakasénas Lithuania 11 240 1.3× 62 0.4× 111 1.0× 44 0.6× 35 0.6× 13 352

Countries citing papers authored by Alix Collard

Since Specialization
Citations

This map shows the geographic impact of Alix Collard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alix Collard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alix Collard more than expected).

Fields of papers citing papers by Alix Collard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alix Collard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alix Collard. The network helps show where Alix Collard may publish in the future.

Co-authorship network of co-authors of Alix Collard

This figure shows the co-authorship network connecting the top 25 collaborators of Alix Collard. A scholar is included among the top collaborators of Alix Collard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alix Collard. Alix Collard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Schmidt, Alexander C., Leyi Lin, Luis Javier Martínez-González, et al.. (2017). Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States. American Journal of Tropical Medicine and Hygiene. 96(6). 1325–1337. 53 indexed citations
3.
Huang, Ying, Carlos A. DiazGranados, Holly Janes, et al.. (2016). Selection of HIV vaccine candidates for concurrent testing in an efficacy trial. Current Opinion in Virology. 17. 57–65. 7 indexed citations
4.
Bourguignon, Patricia, Frédéric Clément, Marguerite Koutsoukos, et al.. (2014). Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients. Journal of Immunological Methods. 414. 1–10. 17 indexed citations
5.
Harrer, Thomas, Andreas Plettenberg, Keikawus Arastéh, et al.. (2013). Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: A randomised placebo-controlled study. Vaccine. 32(22). 2657–2665. 15 indexed citations
6.
Braeckel, Eva Van, Patricia Bourguignon, Marguerite Koutsoukos, et al.. (2011). An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers. Clinical Infectious Diseases. 52(4). 522–531. 50 indexed citations
7.
Espinoza, Félix, Miguel Tregnaghi, Ángela Gentile, et al.. (2010). Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial. BMC Infectious Diseases. 10(1). 297–297. 11 indexed citations
8.
Knuf, Markus, Heinz‐Josef Schmitt, Jeanne‐Marie Jacquet, et al.. (2010). Booster Vaccination After Neonatal Priming with Acellular Pertussis Vaccine. The Journal of Pediatrics. 156(4). 675–678. 37 indexed citations
9.
Chatterjee, Sukanta, et al.. (2010). The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule. BMC Infectious Diseases. 10(1). 298–298. 12 indexed citations
10.
11.
12.
13.
14.
Razavi, Darius, et al.. (1999). Comparative Study of the Efficacy and Safety of Trazodone versus Clorazepate in the Treatment of Adjustment Disorders in Cancer Patients: A Pilot Study. Journal of International Medical Research. 27(6). 264–272. 28 indexed citations
15.
Coppe, P., et al.. (1994). Characterization of a high molecular weight antigen of Cryptosporidium parvum micronemes possessing epitopes that are cross-reactive with all parasitic life cycle stages.. PubMed. 25(4). 384–98. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miroslav Špliňo Breakdown of academic impact, for papers by James Matthias Breakdown of academic impact, for papers by Alemnew F. Dagnew Breakdown of academic impact, for papers by Amalia Magaret Breakdown of academic impact, for papers by Jason Martin Breakdown of academic impact, for papers by Sarah Gwyn Breakdown of academic impact, for papers by Richard Garceau Breakdown of academic impact, for papers by Wen‐Chun Liu Breakdown of academic impact, for papers by I Vodopija Breakdown of academic impact, for papers by V. Bakasénas
Rankless by CCL
2026